MRNA Jan 2024 350.000 call
| Previous close | 8.30 |
| Open | 8.30 |
| Bid | 0.00 |
| Ask | 0.00 |
| Strike | 350.00 |
| Expiry date | 2024-01-19 |
| Day's range | 8.30 - 8.30 |
| Contract range | N/A |
| Volume | |
| Open interest | 496 |
- Editor's pickYahoo Finance Video
FDA backs adjusting COVID booster to new variants, RH and TSM stocks down
Yahoo Finance Live looks at several of the day's trending stocks, including volatility in the semiconductor industry and Pfizer and Moderna opting to enhance COVID-19 booster shots to provide protection against new subvariants.
- Editor's pickYahoo Finance
Omicron: Experts want more data to guide US targeting of fall boosters
The FDA is asking COVID-19 vaccine makers to test and produce boosters that target both the original and new BA.4/BA.5 strains of the virus by fall.
- Motley Fool
Why This Company Could See Long-Lasting Tailwinds Despite the Bear Market
Life sciences company Thermo Fisher Scientific (NYSE: TMO) played an instrumental role in delivering COVID-19 treatments to the world's population. With healthcare spending on the rise, Thermo Fisher is expanding its services in a bid to capture even more of the market. To help address this need, The White House released a Pandemic Preparedness Plan and hopes to increase biodefense spending.
